The effect of clozapine on saliva flow rate: A pilot study

Biological Psychiatry

Volumn 40, Issue 11, 1996, Pages 1132-1134

  Rabinowitz, Terry ^a,b   Frankenburg, Frances R ^a   Centorrino, Franca ^a   Kando, Judith ^a  

^a MCLEAN HOSPITAL   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

clozapine; deglutition; flow; neuroleptic; saliva; sialorrhea

Indexed keywords

CLOZAPINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALIVA;

EID: 0030560925     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)89255-9     Document Type: Article

References (19)

1. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaff JA (1993): Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 329:162-167.
2. Baldessarini RJ, Frankenburg FR (1991): Clozapine. A novel antipsychotic agent. N Engl J Med 324:746-754.
3. Baum BJ ( 1993): Principles of saliva secretion. Ann N Y Acad Sci 694:17-23.
4. Bieger D (1993): Central nervous system control mechanisms of swallowing: A neuropharmacological perspective. Dysphagia 8:308-310.
5. Bourke GJ, Daly LE, McGilvray J (1985): Interpretation and Uses of Medical Statistics, 3rd ed. Oxford: Blackwell Scientific Publications.
6. Davenport HW (1982): Physiology of the Digestive Tract, 5th ed. Chicago: Year Book Medical Publishers, Inc.
7. Grohmann R, Ruther E, Sassim N, Schmidt LG (1989): Adverse effects of clozapine. Psychopharmacology (Berl) 99(suppl): S101-S104.
8. Hyman SE, Nestler EJ (1993): The Molecular Foundations of Psychiatry. Washington, DC: American Psychiatric Press, Inc.
9. Jann MW (1991): Clozapine. Pharmacotherapy 11:179-195.
10. Kaplan MD, Baum BJ (1993): The functions of saliva. Dysphagia 8:225-229.
11. Lieberman JA, Kane JM, Johns CA (1989): Clozapine: Guidelines for clinical management. J Clin Psychiatry 50:329-338.
12. Lindstrom LH (1988): The effect of long-term treatment with clozapine in schizophrenia: A retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 77:524-529.
13. Martin RE, Sessle BJ (1993): The role of the cerebral cortex in swallowing. Dysphagia 8:195-202.
14. McCarthy RH, Terkelsen KG (1994): Esophageal dysfunction in two patients after clozapine treatment. J Clin Psychopharmacol 14:281-283.
15. Miller AJ (1993): The search for the central swallowing pathway: The quest for clarity. Dysphagia 8:185-194.
16. Naber D, Leppig M, Grohmann R, Hippius H (1989): Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia - A retrospective study of 387 patients. Psychopharmacology (Berl) 99(suppl):S73-S76.
17. Pearlman C (1994): Clozapine, nocturnal sialorrhea, and choking. J Clin Psychopharmacol 14:283.
18. Sreebny LM, Broich G (1987): Xerostomia (dry mouth). In Sreebny LM (ed), The Salivary System. Boca Raton, FL: CRC Press, Inc. 179-202.
19. Van Tol HHM, Bunzow JR, Guan H-C, et al (1991): Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614.